Pfizer India Q2 Results | The EBITDA margin stood at 32.2% in the reporting quarter versus 31.7% in Q2 of the previous fiscal. Shares of Pfizer Ltd ended at ₹5,261.45, down by ₹47.25, or 0.89%, on the BSE.
Pfizer India Q2 Results | The EBITDA margin stood at 32.2% in the reporting quarter versus 31.7% in Q2 of the previous fiscal. Shares of Pfizer Ltd ended at ₹5,261.45, down by ₹47.25, or 0.89%, on the BSE.